logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iii) All outpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge knownAge not known
Opiates7.940.928.312.15.72.81.30.821.88984116815
Cocaine9.138.426.013.16.83.71.80.922.3439503811
Stimulants15.555.917.86.22.71.10.60.419.363321151
Hypnotics and sedatives10.025.417.213.510.79.37.26.727.02482761
Hallucinogens9.423.914.39.87.97.88.618.330.4837168
Volatile substances36.531.516.52.77.70.43.80.819.6260181
Cannabis 41.247.37.82.20.80.50.20.116.8431306755
Other substances 26.133.615.95.25.38.73.22.121.811051247
Total16.342.022.49.84.82.61.30.820.818793730889

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain refer to 2007, for Malta refer to 2006 and for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010